ライフサイエンスコーパス: consensus on

1 Panellists reached consensus on 11 major criteria for referral: severe phys

2 participants completing both rounds) reached consensus on 42% (n = 46) of 110 items.

3 roup of more than 50 stakeholders to develop consensus on a core set of data elements and values esse

4 e iterative rounds, the expert panel reached consensus on a critical care content outline.

5 se the practice of growth monitoring, with a consensus on a few priority target conditions and with i

6 29, 2016), ICHOM led the working group to a consensus on a final recommended standard set.

7 this issue, we did a Delphi study to develop consensus on a list of criteria for referral of patients

8 However, there is still no consensus on a mechanistic model that explains how magma

9 view, surveys, and cohort studies to achieve consensus on a new septic shock definition and clinical

10 However, there is still no consensus on a reliable safety indicator able to predict

11 Our objective was to obtain international consensus on a set of core outcome measures that should

12 Life Cycle Initiative is engaged in building consensus on a shared modeling framework to highlight be

13 ns with health outcomes is needed to develop consensus on a standard EO definition.

14 al dosage forms, there is currently no clear consensus on a standard for in vitro drug dissolution st

15 However, there is no consensus on a treatment threshold that is safe but also

16 Although there is no clear consensus on a unified hypothesis, it seems likely that

17 Author consensus on aetiology divided into, 'probably functiona

18 Despite broad consensus on Africa as the main place of origin for anat

19 However, the field lacks a consensus on analysis and result interpretation.

20 tance of method selection and the need for a consensus on approaches appropriate for particular loads

21 Evidence-based consensus on appropriate indications for surgery is urge

22 However, there is no consensus on best practices for the medical management o

23 luate the current literature and establish a consensus on best practices to be implemented in MIA stu

24 However, there is no consensus on biochemical targets of artemisinin.

25 These statements are intended to serve as a consensus on candidate quality indicators for those who

26 The four tools returned poor consensus on candidates (only 20% of calls were with mul

27 This 2020 International Consensus on Cardiopulmonary Resuscitation (CPR) and Eme

28 e first of an annual series of International Consensus on Cardiopulmonary Resuscitation and Emergency

29 This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency

30 This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency

31 For this 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency

32 This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency

33 son Committee on Resuscitation International Consensus on Cardiopulmonary Resuscitation and Emergency

34 ncludes 5 basic life support and 1 pediatric Consensuses on Cardiopulmonary Resuscitation and Emergen

35 it inferences consistent with the scientific consensus on climate change among conservatives exposed

36 The aim of this work was to reach a consensus on clinical endpoints to consider in future cl

37 survey approach was used to ascertain expert consensus on core components of asthma remission as a tr

38 However, due to the lack of a general consensus on critical characterization parameters, a sho

39 n appropriate attention, and there is little consensus on damping models.

40 However, to achieve this, consensus on definitions of analytical techniques, propo

41 No consensus on definitions of prediabetes exists among int

42 hting relevant missing items but provides no consensus on design and wording preferences.

43 There was no consensus on dosage and patient selection.

44 ted the data from stage 1, aiming to achieve consensus on each issue.

45 ing studies have, however, so far reached no consensus on either the sign or physical mechanism of El

46 On the basis of these studies, we propose a consensus on evidence-based rather than idiosyncratic cr

47 nd international meetings were held to reach consensus on evidence-based statements.

48 This Review provides an up-to-date consensus on exercise management for individuals with ty

49 mittee on Resuscitation's 2020 International Consensus on First Aid Science With Treatment Recommenda

50 The Consensus on Health Economic Criteria checklist was used

51 Quality assessment was performed using the Consensus on Health Economic Criteria instrument (scored

52 previous climate models have provided little consensus on historical and projected trends in coastal

53 y associated with mortality, but there is no consensus on how best to assess abdominal adiposity.

54 There is a clear need for consensus on how best to follow up patients with Fontan

55 Attaining this goal will require a consensus on how best to measure the numbers of persiste

56 to the renal allograft, yet there remains no consensus on how best to monitor drug therapy.

57 eatment modalities for AF, there is no clear consensus on how best to treat AF with concomitant HFrEF

58 However, there is no consensus on how best to treat these patients.

59 review, we present the basis for an emerging consensus on how dynamin functions.

60 w of contemporary modelling studies, that no consensus on how future changes in climatic conditions w

61 ion methods have been developed, there is no consensus on how methods compare to each other.

62 However, there is no consensus on how MIF levels differ in COPD compared to c

63 onal diversity and identity, but there is no consensus on how neuron types should be defined.

64 In this article, we present a consensus on how non-invasive in vivo assessment of locu

65 ENT The neuroscience literature yet to reach consensus on how the hippocampus supports the organizati

66 However, there is currently no consensus on how the modern methods compare to one anoth

67 The lack of consensus on how the quality of structural alignments mu

68 Further, there is no consensus on how the search for one should be refocussed

69 ange of biomes, there is surprisingly little consensus on how the spatiotemporal patterns of Rs will

70 There is no consensus on how this family of proteins might function

71 2,000 y before present; however, there is no consensus on how this migration occurred: toward the nor

72 been left to users to construct without much consensus on how this should be done, albeit it has been

73 Despite there being consensus on how TMAO and urea affect proteins as a whol

74 However, there is currently no consensus on how to assess or quantify NETosis in vivo,

75 A general consensus on how to best screen for and manage acute HCV

76 e many voices raised on the issue, we lack a consensus on how to define and categorize plastic debris

77 Currently, there is no consensus on how to define chikungunya chronicity.

78 greement underlies these debates: There's no consensus on how to define empathy.

79 (HFpEF) is common, yet there is currently no consensus on how to define HFpEF according to various so

80 The lack of consensus on how to define macrophage activation in expe

81 on-responders' is common - despite a lack of consensus on how to define these groups.

82 nical practice has been limited by a lack of consensus on how to measure it.

83 y seen in isolation, to date there exists no consensus on how to model it.

84 rug combinations continues to accelerate, no consensus on how to quantify drug synergy has emerged.

85 We also summarise the consensus on how to treat testicular germ cell tumours a

86 There is a lack of consensus on how we define heart failure with preserved

87 There is no consensus on how, when, or at what intensity exercise sh

88 To work toward consensus on improving the environment for cardiovascula

89 This report describes in detail the CAM consensus on iRORA.

90 Consensus on items to be included in the criteria.

91 n ice-house world, yet there is still little consensus on its causes, in part because carbon cycle dy

92 phase breaks various symmetries, there is no consensus on its fundamental nature(1).

93 is a heterogeneous disease that lacks clear consensus on its ideal management.

94 , but biochemical studies have not reached a consensus on its primary enzymatic activity.

95 Thus, there is an urgent need for a consensus on key food allergy parameters to be applied i

96 While there is some consensus on key relationships among their members, on t

97 Moreover, there is no consensus on management, and therapeutic options may be

98 et (> 34 weeks) FGR; as a result there is no consensus on management.

99 or barrier to these trials is the absence of consensus on measurement of treatment effectiveness.

100 Reaching consensus on measures and consistency in data collection

101 strategies, attributable in part to lack of consensus on methods of estimation and the importance of

102 andardisation across different settings, and consensus on methods to address confounders will maintai

103 ored the validity of the First International Consensus on Mucous Membrane Pemphigoid (MMP) guidance,

104 iple tau-imaging tracers in order to reach a consensus on normal and abnormal tau imaging values that

105 ablished which patients are at risk, with no consensus on optimal follow-up.

106 critical review of the literature showed no consensus on optimal methods of PRO analysis in cancer R

107 tion for major surgery, there remains little consensus on optimal strategies, due to the lack of inst

108 ar screening guidelines still exist, with no consensus on optimum screening strategies or treatment t

109 However, there is no clear consensus on perfusion protocols.

110 r: 0.559) correlated significantly with the consensus on physician-scored mediator symptoms.

111 nt of LRRK2 kinase inhibitors; however, poor consensus on physiological LRRK2 substrates has hampered

112 There remains a need for consensus on practical aspects of mycophenolate target c

113 evidence of Buruli ulcer in 32 countries and consensus on presence in 12.

114 nically important research gaps, and develop consensus on priorities for future research.

115 iological and toxicological studies to reach consensus on probabilities of causation for 15 exposure-

116 provide an evidence-based and expert-opinion consensus on proposed modifications to MRI criteria for

117 There is also lack of consensus on quantification of disease severity in chron

118 ed, including the challenge of arriving at a consensus on rankings/scorings.

119 se intrinsic pontine glioma and to develop a consensus on recommendations for response assessment.

120 his approach through discussion; and reached consensus on recommendations regarding updated eligibili

121 Results Consensus on reference values was initially weak for 232

122 Consensus on reporting guidelines was reached through a

123 tion in the sea over many years, but with no consensus on results.

124 Consensus on robust markers and their conversion to "glu

125 ted participants) was conducted to establish consensus on SAPs.

126 Whereas the 2010 ILCOR Consensus on Science provided important direction for th

127 and summarize the evidence and to provide a consensus on science statement and treatment recommendat

128 mittee on Resuscitation First Aid Task Force Consensus on Science With Treatment Recommendations.

129 Topics for which systematic reviews and new Consensuses on Science With Treatment Recommendations we

130 Consensus on SDD detection methods is recommended to adv

131 We provide a multinational expert consensus on separate hierarchical composite endpoints f

132 es achievement of collective goals, generate consensus on solutions, and find an effective public pos

133 iculties in the field has been determining a consensus on spectral pre-processing and data analysis.

134 ess of ratings and comments yielded a strong consensus on standards for skin imaging in dermatology p

135 ess of ratings and comments yielded a strong consensus on standards for skin imaging in dermatology p

136 Although there is no consensus on terminology, we refer to these patients as

137 An international consensus on terms and descriptions was reached on multi

138 recent developments that suggest an emerging consensus on the ability of different cell types to rege

139 However, there is no good consensus on the amount, distribution and alignment of t

140 y of therapeutic proteins, there is no clear consensus on the approaches to identify and validate the

141 As of yet, a clear consensus on the basic surface/interfacial properties of

142 Sharing experience and developing expert consensus on the basis of evolving publications will hel

143 There is no consensus on the benefit of red blood cell (RBC) transfu

144 Furthermore, there is no consensus on the best approach for dealing with variabil

145 However, at present, there is no consensus on the best method to profile exRNA expression

146 To achieve consensus on the best practices in the management of ven

147 There is no universal consensus on the best staging system for chronic obstruc

148 There is no consensus on the best way to integrate biomarkers into i

149 The challenge now is to reach a consensus on the best way to sequence effective treatmen

150 al and temporal variability, but there is no consensus on the biophysical mechanisms that drive stem

151 ility of Earth's ecosystems, but there is no consensus on the causal relationships linking these vari

152 shed as unique neuron types, there is little consensus on the classification of GPe neurons.

153 2019 (COVID-19) pandemic revealed a lack of consensus on the concept of essential oral health care.

154 There is no global consensus on the conduct of clinical trials in children

155 At present, there is no consensus on the conformation of the APP-TM domain at th

156 certain mysteries remain, such as a lack of consensus on the cooperativity of thiamine pyrophosphate

157 Then expert panel discussions achieved consensus on the core outcomes, the methods to measure t

158 lation after cardiac arrest, and it provides consensus on the current evidence supporting elements of

159 f current clinical trials to provide a broad consensus on the current state of the art in noncoding R

160 To develop a consensus on the definition and measurement of effective

161 To date, there is no consensus on the definition of low expression.

162 pertains to framing: generation of internal consensus on the definition of the problem and solutions

163 national collaboration intended to establish consensus on the definition, classification, and assessm

164 Consensus on the definitions of iron repletion and exces

165 There is no consensus on the degree of thoracolumbar flexion to defi

166 ical Care Medicine Program Directors reached consensus on the detailed curricular content and expecte

167 Clear consensus on the diagnosis, management, and monitoring o

168 There is no scientific consensus on the drivers of this slowdown.

169 There is, however, no consensus on the elements that constitute an ideal ACS m

170 ot been reported, and currently, there is no consensus on the endothelial function of individual Pak

171 d composition database organizations reached consensus on the EuroFIR quality framework and started i

172 Moreover, there is still no consensus on the exact percentage of glenoid loss that r

173 high-impedance leads(15-19), although a full consensus on the existence of extended phase fluctuation

174 ntation can influence food web interactions, consensus on the factors underlying variation in the imp

175 To date, there is no consensus on the FM origin in Cu/Cu2O systems.

176 their importance for humans, there is little consensus on the function of antibiotics in nature for t

177 To date, there is still no general consensus on the fundamental principle that governs glas

178 tions (UN) leadership to build international consensus on the future of MRT.

179 Today, new consensus on the genetic and clinical diagnosis of neuro

180 mon medical complaint, there is currently no consensus on the global prevalence of GORD.

181 The current consensus on the identity of the major organic SEI compo

182 Despite its high incidence, there is no consensus on the implications of PAE on metabolic diseas

183 There is currently no consensus on the importance of climate change in Mesoame

184 There is little scientific consensus on the importance of external climate forcings

185 lt kidney transplantation, there is no clear consensus on the incidence of graft failure-due-to nonco

186 neuroimaging data; however, there is little consensus on the localization of such hubs.

187 n of carbon in soil is significant, and some consensus on the magnitude of that potential.

188 A lack of consensus on the management of bleeding complications in

189 ors, and the struggle to reach international consensus on the management of migratory species.

190 There are limited data and consensus on the management of the refractory TTP patien

191 ionally, there has been an important lack of consensus on the management of these complications, whic

192 roblem seems obvious: Nurses need to reach a consensus on the meaning and definition of empathy.

193 iscovery of these neurons, there is still no consensus on the mechanism underlying direction selectiv

194 This document is the result of a consensus on the mechanisms of exercise-induced anaphyla

195 Currently, there is no consensus on the mechanisms that lead to these observed

196 ardiorespiratory fitness, and to the lack of consensus on the MHO definition.

197 However, there is a lack of consensus on the molecular mechanism by which alcohol me

198 analysis of such datasets, there is no clear consensus on the most reliable computational methods for

199 the research community has failed to reach a consensus on the nature and significance of the relation

200 d risk factors for neoplasia, so there is no consensus on the need for pouch surveillance.

201 New or modified elements reflected consensus on the need to account for emergency medical s

202 There is expanding consensus on the need to modernize the training of cance

203 T data with variable uptake intervals and no consensus on the number of lesions to be assessed.

204 aught through varying curricula; however, no consensus on the optimal curriculum has been established

205 se component endpoints; however, there is no consensus on the optimal instrument for use in clinical

206 Background There currently is no consensus on the optimal localization procedure and imag

207 To date, there is no consensus on the optimal pathway of the transitional car

208 However, there remains a lack of consensus on the optimal route and dosage of TAM adminis

209 tem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery.

210 tem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery.

211 e increasing the use of stem cell therapies, consensus on the optimal stem cell type is not adequatel

212 Purpose There is no consensus on the optimal systemic treatment of patients

213 In this Position paper, we provide a consensus on the optimal use and terminology for cancer

214 Despite intense study, there is no consensus on the organization of monomers within Sup35NM

215 etic response but weak lattice character, no consensus on the origin of this transition has been reac

216 ed 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be i

217 teomic evidence, but there remains a lack of consensus on the performance of different quality contro

218 At present, however, there is no consensus on the phenotypic signature of Bregs, and thei

219 t conditions and fluid properties, without a consensus on the physical mechanisms responsible for the

220 aim of the current document was to propose a consensus on the position and gradual implementation of

221 They reached a consensus on the presence or absence of 6 radiological f

222 However, empirical tests lack consensus on the prevalence of such mismatches and their

223 However, there is no general consensus on the processes involved, and the mechanism o

224 te this enzyme having been widely studied, a consensus on the reaction mechanism has not yet been fou

225 y makers and researchers is the absence of a consensus on the relation of beverages containing low-ca

226 ves have fundamentally altered a decades-old consensus on the relationships of extinct gnathostomes,

227 However, there is no consensus on the relative importance of drainage and imb

228 However, there was no consensus on the relevance of REA, including how each of

229 among 24 experts from 10 countries to reach consensus on the requirements for TO in pancreatic surge

230 lay an important role but there is a lack of consensus on the role of understanding what happened in

231 There is no international consensus on the safe minimum numbers of acute, forensic

232 An expert panel made judgements, and reached consensus on the same scenarios.

233 espite its importance, there is currently no consensus on the statistical analysis of the resulting d

234 No consensus on the strategy for screening, recommended tar

235 ansplant centers use antifungal prophylaxis, consensus on the strategy, choice of antifungal agent(s)

236 There is no consensus on the surgical management of head position as

237 logy), convened a working group to develop a consensus on the syndrome of myocardial ischemia with no

238 Although a consensus on the timing of initiation of treatment, the

239 ever, after decades of research, there is no consensus on the true equilibrium (18)O/(16)O fractionat

240 nditions of truth abandonment and reaching a consensus on the truth.

241 hemical cycling; however, there is a lack of consensus on the uncertainty magnitude.

242 y, reliability, availability, and a national consensus on the use of PLB.

243 There is currently no clear consensus on the value of SPVL heritability, as multiple

244 topsy practice clearly relate to the lack of consensus on their broader utility as well as to a lack

245 Despite decades of study, there is still no consensus on their emission mechanism.

246 gnostic microbiology, there is no comparable consensus on their handling prior to culture-independent

247 or prognostic lesions, and there has been no consensus on their risk status.

248 Currently, there is no consensus on their specific physiological role.

249 sus" when in the literature there is no such consensus on these issues.

250 Results show widespread consensus on these meanings within society and demonstra

251 The lack of strong evidence and expert consensus on these topics has identified gaps in knowled

252 The attendees continued to work toward consensus on these topics, and present the key findings

253 ous AMPK transgenic animals have not reached consensus on this matter.

254 lant function and vegetation dynamics, but a consensus on those mechanisms has yet to emerge.

255 ateral retinoblastoma (TRB), but there is no consensus on timing or frequency of screening worldwide.

256 ders was held in September 2016 to develop a consensus on treatment endpoints to guide the design of

257 for primary and safety outcomes, and lack of consensus on treatment parameters.

258 genotype-phenotype correlation; there is no consensus on treatment.

259 ttention from ecologists but there is little consensus on underlying causes.

260 In our opinion, there is a strong need for a consensus on universally accepted measuring techniques o

261 Remarkably, there is little consensus on using the value of MPV in the prognostic ev

262 d modified Delphi method was used to achieve consensus on voting statements and RAND/UCLA Appropriate

263 and in mathematical studies, but there is no consensus on what actually takes place in the ocean.

264 This study found no consensus on what bringing a complex systems perspective

265 There is no consensus on what constitutes a positive family history,

266 However, there is little consensus on what constitutes nonpredicted stimuli.

267 To the southeast there is no consensus on what constitutes the northern boundary of t

268 of LPB have been proposed, there is still no consensus on what mechanism(s) generate LPB or even on w

269 oadmap for which the first output would be a consensus on what outcome domains are essential for all

270 There is at present no consensus on what produces such orbits.

271 There seems to be no consensus on what the most common properties are, but sc

272 n on treatment response, but there is rarely consensus on what the subjective prior beliefs should be

273 etical exposures do not exist or there is no consensus on what they might be.

274 This public consensus on what types of asylum seekers to accept has

275 to identify areas of controversy, as well as consensus, on what is and is not yet known about how cho

276 ight chain (AL) amyloidosis, there is little consensus on when reinstitution of chemotherapy should o

277 e ecology community has struggled to come to consensus on whether biodiversity reduces or increases i

278 ous field studies have reached no collective consensus on whether Bt corn, the most commonly planted

279 nd abiotic stress responses, but there is no consensus on whether elevated CO(2) constitutes a stress

280 Currently, there is no consensus on whether heart beat or respiration is the ma

281 There is no consensus on whether magnetic resonance imaging (MRI) sh

282 are energetically costly yet there is little consensus on whether or how such costs might influence s

283 There is also no consensus on whether tubulin is a peripheral membrane pr

284 origins and proper treatment of zeros and no consensus on whether zero-inflated count distributions a

285 sclerosis (ALS); however, there is still no consensus on which biomarkers are reliable prognostic fa

286 verse, ranging from 0.01 to 0.4, with little consensus on which factors account for these differences

287 recision medicine for PDAC might be the poor consensus on which genetic and phenotypic alterations ac

288 There is no consensus on which HKGs are most stably expressed in end

289 of coercion, and fully informed, there is no consensus on which information should be provided, and h

290 data for trading is unclear due to a lack of consensus on which instruments can be predicted and how.

291 filtration rate (GFR); however, there is no consensus on which is superior for risk classification i

292 In addition to the absence of current consensus on which patients should be included in the re

293 There was little consensus on which questions within the population domai

294 Despite intensive research, there is no consensus on which step is rate-limiting for these enzym

295 nd typical participants, and there is little consensus on which tracts are affected.

296 aches consensus, or a mechanism for evolving consensus, on which results should be returned to resear

297 e-care clinics improve outcomes, there is no consensus on who should be referred or the optimal timin

298 for species persistence, but there is little consensus on why individual species vary so greatly in t

299 patients and their families in ICU to reach consensus on withdrawal of aggressive treatment and shif

300 ing patients' use with families to negotiate consensus on withdrawal of aggressive treatment and/or s